Sep 27, 2021 08:24 AM IST
The company has received the import and market permission in Form CT-20 from the Drugs Controller General of India for Selumetinib 10 mg & 25 mg capsules, AstraZeneca Pharma India said in a regulatory filing.
- Sep 14, 2021 10:03 PM IST
On August 11, the Drug Controller General of India issued its nod to the Christian Medical College in Vellore to conduct the trials on mixing of Covishield and Covaxin vaccines.
- Sep 03, 2021 03:44 PM IST
It also received approval for the Phase 2/3 study to evaluate the “safety, reactogenicity, tolerability and immunogenicity” of Corbevax in children and adolescents.
- Jul 09, 2021 09:00 AM IST
In a two-stage approach, the phase 3 clinical study will initially investigate the efficacy of the COVID-19 vaccine formulation targeting the original novel coronavirus strain.
- Jun 01, 2021 04:45 PM IST
DRDO stated that the medicine can be given to Covid patients under the care and prescription of doctors.
- Apr 23, 2021 03:17 PM IST
The company has claimed that 91.15 percent of COVID-19 patients treated with Virafin were RT-PCR negative by day 7.
- Mar 29, 2021 09:14 PM IST
Bharat Biotech signed a master collaborative agreement with Biovet and Sapigen Biologix. Under the agreement all the firms would provide necessary financial support to CSIR-IICT for developing key raw materials.
- Feb 22, 2021 09:27 PM IST
Baba Ramdev-promoted company launched the medicine at an event where Dr Harsh Vardhan and Nitin Gadkari were present. WHO issued a clarification stating that no traditional medicine for COVID-19 had been reviewed or certified.
- Jan 12, 2021 09:09 AM IST
Pfizer failed to present before the Subject Expert Committee (SEC) on vaccines in India on three occasions
- Jan 08, 2021 11:28 AM IST
Besides Covaxin, Bharat Biotech has been actively working on developing another vaccine, for which it tied up with Washington University School of Medicine in St Louis for the novel "chimp-adenovirus" (Chimpanzee adenovirus), a single dose in tranasal vaccine for COVID-19.
- Jan 04, 2021 05:10 PM IST
The Hyderabad-based firm is conducting Phase III trials. Covaxin is yet to complete late-stage human clinical trials in India.
- Jan 03, 2021 05:46 PM IST
The company will now be initiating Phase III clinical trial in around 30,000 volunteers, Zydus Cadila said in a statement.
- Jan 03, 2021 12:54 PM IST
India's drugs regulator DCGI on Sunday approved Oxford's COVID-19 vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use.
- Dec 21, 2020 11:16 AM IST
AstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt of related statutory approvals and licenses.
- Dec 21, 2020 11:00 AM IST
Emphasising “atmanirbharta” or self-reliance, the minister said India’s focus is on developing an indigenous vaccine, adding that our vaccine manufacturing capacities “are not less than anyone.”
- Dec 11, 2020 07:30 PM IST
The firm has received conditional permission for Phases 1 and 2 human clinical trials. The subject expert committee has reviewed its proposal before giving the conditional nod.
- Dec 02, 2020 10:12 PM IST
ICMR Director General Dr Balram Bhargava had on Tuesday said adverse events do occur with drugs or vaccines or any other health intervention.
- Nov 03, 2020 09:28 AM IST
Dr Reddy’s proposal comes after the USFDA granted remdesivir full regulatory status – making it the first COVID-19 drug to receive full approval
- Oct 12, 2020 09:02 AM IST
The Feluda paper strip test for SARS-CoV-2 diagnosis has been developed by CSIR-IGIB and was earlier approved by the Drug Controller General of India for a commercial launch.
- Sep 12, 2020 01:01 PM IST
DCGI Dr V G Somani on Friday also directed Serum Institute of India (SII) to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.
- Jul 30, 2020 08:10 AM IST
The Serum Institute of India had submitted its application to the DCGI on July 24, seeking permission for conducting the phase 2 and 3 trials of the potential vaccine 'Covidshield'.
- Jul 27, 2020 07:25 PM IST
The much-awaited trial of BBV152 COVID-19 vaccine or Covaxin commenced at the Institute of Medical Sciences and SUM Hospital, one of the 12 centres selected by Indian Council of Medical Research (ICMR) for conducting phase one and two of the process, the official at the facility said.
- Jul 14, 2020 01:45 PM IST
Besides DCGI's nod to produce the active pharmaceutical ingredient in India, it has been cleared for exports as well.
- Jul 08, 2020 12:52 PM IST
Remdesivir with MRP of Rs 5,400 is reportedly being sold for even Rs 60,000 with medical shops telling customers the drug is in short supply and can be made available at an inflated price.
- Jul 04, 2020 07:00 PM IST
The company has received import and market permission from DCGI in Form CT-20 (Marketing Authorisation- Additional Indication).